Clinical characteristics and outcomes of patients with COVID‐19 and psoriasis
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Medical Virology"
DOI: 10.1002/jmv.28085
Abstract: To summarize the clinical characteristics and explore the role of treatment types in outcomes among psoriasis patients with coronavirus disease 2019 (COVID‐19). The principal summary measures were pooled prevalence and risk ratio (RR) with 95%… read more here.
Keywords: biologic therapy; analysis; psoriasis patients; psoriasis ... See more keywords
Biologic therapy in the idiopathic inflammatory myopathies
Sign Up to like & getrecommendations! Published in 2019 at "Rheumatology International"
DOI: 10.1007/s00296-019-04467-6
Abstract: The idiopathic inflammatory myopathies (IIM) are a group of autoimmune diseases resulting from inflammation of muscle and manifesting as weakness, though a range of extra-muscular manifestations are observed. These are often correlated closely with disease… read more here.
Keywords: inflammatory myopathies; idiopathic inflammatory; biologic therapy; therapy idiopathic ... See more keywords
Biologic Therapy for Moderate to Severe Psoriasis. Real-World Follow-up of Patients Who Initiated Biologic Therapy at Least 10 Years Ago
Sign Up to like & getrecommendations! Published in 2022 at "Dermatology and Therapy"
DOI: 10.1007/s13555-022-00693-2
Abstract: The aim of this study was to evaluate response and drug survival of biologic therapy in patients with moderate to severe plaque-type psoriasis who initiated biologic therapy at least 10 years ago, in a real-world… read more here.
Keywords: study; therapy; moderate severe; psoriasis ... See more keywords
Management of Biologic Therapy in Moderate to Severe Psoriasis in Surgical Patients: Data From the Spanish Biobadaderm Registry.
Sign Up to like & getrecommendations! Published in 2017 at "Actas dermo-sifiliograficas"
DOI: 10.1016/j.ad.2016.08.003
Abstract: BACKGROUND AND OBJECTIVE We now have considerable experience in the use of biologic agents to treat psoriasis, but doubts about management arise in certain clinical settings. Surgery is one of them. Although treatment guidelines advise… read more here.
Keywords: treatment; biologic therapy; management; management biologic ... See more keywords
Inflammatory eye disease: Pre-treatment assessment of patients prior to commencing immunosuppressive and biologic therapy: Recommendations from an expert committee.
Sign Up to like & getrecommendations! Published in 2017 at "Autoimmunity reviews"
DOI: 10.1016/j.autrev.2017.01.003
Abstract: AIM To outline recommendations from an expert committee on the assessment and investigation of patients with severe inflammatory eye disease commencing immunosuppressive and/or biologic therapy. METHOD The approach to assessment is based on the clinical… read more here.
Keywords: biologic therapy; disease; therapy; inflammatory eye ... See more keywords
[Uveitis treated with biotherapy and/or DMARD: Analysis from the French Pharmacovigilance Study Base].
Sign Up to like & getrecommendations! Published in 2018 at "Journal francais d'ophtalmologie"
DOI: 10.1016/j.jfo.2017.11.012
Abstract: PURPOSE To report the characteristics of uveitis cases occurring while on biologic therapy or disease-modifying antirheumatic drugs (DMARDs) reported to the French national pharmacovigilance database. METHODS All the uveitis cases occurring in patients with chronic… read more here.
Keywords: dmard; uveitis treated; biologic therapy; pharmacovigilance ... See more keywords
Second-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
Sign Up to like & getrecommendations! Published in 2017 at "Seminars in arthritis and rheumatism"
DOI: 10.1016/j.semarthrit.2017.03.008
Abstract: OBJECTIVE The Italian board for the TAilored BIOlogic therapy (ITABIO) reviewed the most consistent literature to indicate the best strategy for the second-line biologic choice in patients with rheumatoid arthritis (RA), spondyloarthritis (SpA), and psoriatic… read more here.
Keywords: biologic therapy; anti tnf; line biologic; arthritis ... See more keywords
Complications of biologic therapy for pediatric cancer - What the surgeon needs to know.
Sign Up to like & getrecommendations! Published in 2019 at "Seminars in pediatric surgery"
DOI: 10.1016/j.sempedsurg.2019.150863
Abstract: Biologic therapy for pediatric cancer has gained much enthusiasm over the past two decades. Recent advances in the clinical sequencing of tumors, have also allowed for the identification of targetable mutations. These findings have created… read more here.
Keywords: biologic therapy; pediatric cancer; therapy pediatric; therapy ... See more keywords
Less prevalent use of biologics for inflammatory bowel disease in patients from Non-Academic hospitals – a Danish register-based study of a region with 580,000 citizens
Sign Up to like & getrecommendations! Published in 2022 at "Scandinavian Journal of Gastroenterology"
DOI: 10.1080/00365521.2022.2143726
Abstract: Abstract Introduction Biologic therapy is widely used for inflammatory bowel disease (IBD) and may decrease surgery rates. However, it remains uncertain if there is unwarranted geographic variation in access to biologic therapy. The aim of… read more here.
Keywords: inflammatory bowel; region; patients non; biologic therapy ... See more keywords
Long-term outcomes of combination biologic therapy in uncontrolled severe asthma: a case study
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Asthma"
DOI: 10.1080/02770903.2022.2109162
Abstract: Abstract Introduction Treatment with biologics has significantly reduced the social and economic burden of severe asthma. However, some patients may still feature a suboptimal control of their symptoms while on therapy. In this subset of… read more here.
Keywords: combination biologic; asthma; therapy; biologic therapy ... See more keywords
Biologic therapy in relapsing polychondritis: navigating between options
Sign Up to like & getrecommendations! Published in 2022 at "Expert Opinion on Biological Therapy"
DOI: 10.1080/14712598.2022.2048647
Abstract: ABSTRACT Introduction Relapsing polychondritis (RP) is a rare systemic inflammatory disease of unknown etiology, primarily affecting cartilaginous tissue and proteoglycan-rich structures. Clinical manifestations vary from mild symptoms to occasional organ or life-threatening complications. Treatment can… read more here.
Keywords: biologic therapy; relapsing polychondritis; therapy; therapy relapsing ... See more keywords